Korczynski Sherry
Chief Commercial Officer
Korczynski Sherry has filed 4 SEC Form 4 filings (6 transaction rows) across 1 company, with disclosures dating back to 2026. 4 of those filings fall inside the rolling window. Most recent filing: Sep 11, 2026.
On the most recent filing, Korczynski Sherry is listed as Chief Commercial Officer at Aquestive Therapeutics, Inc. Inside the rolling window, Korczynski Sherry reported no open-market purchases and 2 open-market sales totaling $111K in AQST. The largest disclosed transaction in the window is a sale of 15,741 AQST shares on Mar 10, 2026, worth $66K.
Companies traded
Other insiders at AQST
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$111K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Korczynski Sherry made?
Korczynski Sherry has filed 4 SEC Form 4 filings (6 transaction rows) across 1 company since 2026.
Which companies does Korczynski Sherry trade?
Korczynski Sherry has filed SEC Form 4 disclosures for 1 company, including AQST.
When was Korczynski Sherry's most recent SEC Form 4 filing?
Korczynski Sherry's most recent SEC Form 4 filing on Tracefour is dated Sep 11, 2026.
What is Korczynski Sherry's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Korczynski Sherry is listed as Chief Commercial Officer.
What is Korczynski Sherry's total buy and sell value in the current window?
Inside the rolling retention window, Korczynski Sherry bought $0 and sold $111K based on SEC Form 4 filings.
What was Korczynski Sherry's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 15,741 AQST shares on 2026-03-10, worth $66K, per SEC Form 4 filings.